HLS Therapeutics Inc. (TSX:HLS) is a specialty pharmaceutical company focused on the acquisition and commercialization of late-stage development, clinical innovation, commercial-stage promoted and established branded pharmaceutical products in the North American markets.
HLS is dedicated to the stewardship of branded pharmaceuticals through their life cycle during and post exclusivity, providing access to treatments, devices and diagnostics critical to Health Care Providers, patients and their caregivers with the brand names they trust.